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ABSTRACT 
 
Purpose: Exercise-induced central fatigue is alleviated following acclimatisation to high 
altitude. The adaptations underpinning this effect may also be induced with brief, repeated 
exposures to severe hypoxia. The purpose of this study was to determine whether (i) exercise 
tolerance in severe hypoxia would be improved following an intermittent hypoxic (IH) protocol 
and (ii) exercise-induced central fatigue would be alleviated following an IH protocol. Methods: 
Nineteen recreationally-active males were randomised into two groups who completed ten 2-h 
exposures in severe hypoxia (IH: PIO2 82 mmHg; n=11) or normoxia (control; n=8). Seven 
sessions involved cycling for 30 min at 25% peak power ( peak) in IH, and at a matched heart 
rate in normoxia. Participants performed baseline constant-power cycling to task failure in severe 
hypoxia (TTF-Pre). After the intervention, the cycling trial was repeated (TTF-Post). Pre- and post-
exercise, responses to transcranial magnetic stimulation and supramaximal femoral nerve 
stimulation were obtained to assess central and peripheral contributions to neuromuscular 
fatigue. Results: From pre- to post-exercise in TTF-Pre, maximal voluntary force (MVC), cortical 
voluntary activation (VATMS) and potentiated twitch force (Qtw,pot) decreased in both groups (all 
p < 0.05). Following IH, TTF-Post was improved (535 ± 213 s vs. 713 ± 271 s, p < 0.05) and an 
additional isotime trial was performed. After the IH intervention only, the reduction in MVC and 
VATMS was attenuated at isotime (p < 0.05). No differences were observed in the control group. 
Conclusion: Whole-body exercise tolerance in severe hypoxia was prolonged following a 
protocol of IH. This may be related to an alleviation of the central contribution to neuromuscular 
fatigue. 
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INTRODUCTION 
 
Whole-body exercise tolerance in severe acute hypoxia (AH) is markedly impaired (4,14). The 
reduction in exercise tolerance in AH is not only a concern for mountaineers, but also military 
forces, where tactical necessity can result in rapid ascent of service personnel to high altitude and 
result in debilitating reductions in physical operational capabilities (28). At task failure following 
constant-power cycling in AH, neuromuscular fatigue is evident as a reduction in the ability to 
produce maximal isometric force, with a clear central contribution (4,17,19). Studies utilizing 
transcranial magnetic stimulation (TMS) before and after a fatiguing motor task in AH have 
shown that at least some of the resulting loss of force originates at or upstream of the motor 
cortex (17,19,36). This decrease in cortical voluntary activation (VATMS) occurs alongside 
pronounced cerebral deoxygenation and as such, exercise in AH is considered to be limited 
primarily by the hypoxic central nervous system (CNS) (11,47). Further evidence for this is 
provided from studies using an increase in the partial pressure of inspired O2 (PIO2) at volitional 
exhaustion, where the capacity to resume whole-body exercise occurs too rapidly to be due to a 
reversal of metabolic disturbance in the locomotor muscles (e.g. (4)). 
 
Initial evidence suggests that the mechanisms of exercise-induced fatigue in AH can be 
modulated by the physiological adaptations associated with acclimatization (3,19). A 14-day 
exposure to high altitude (PIO2 76 mmHg) alleviated exercise-induced central fatigue and this 
occurred alongside improvement in indices of systemic and cerebral O2 availability (3,19). 
However, chronic exposure to hypoxia involves substantial logistical demand, immunological 
consequences (27), and risk of acute mountain sickness (AMS) (15). As such, intermittent 
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hypoxia (repeated exposures to sustained hypoxia lasting minutes to hours) via a decrease in 
PIO2, has been investigated as a means of promoting physiological adaptations without a 
prolonged stay at high altitude (or confinement to a hypoxic chamber) (28).  
 
Following acclimatisation, a number of mechanisms may be responsible for an improved 
exercise tolerance in severe hypoxia (41). Hemoglobin concentration [Hb] is higher due to a 
reduction in plasma volume, and O2 carrying capacity is improved via erythropoiesis (measured 
as an increase in total hemoglobin mass (37); Hbmass). Furthermore, hemoglobin saturation 
(SpO2) is increased during hypoxic exercise (3). These mechanisms contribute to an increase in 
arterial O2 content (CaO2) during constant-power cycling in chronic hypoxia in comparison to 
AH (3). However, it is not necessarily the systemic improvement in CaO2 that results in an 
alleviation of central fatigue in chronic hypoxia, but may be the resulting improvement in 
cerebral O2 delivery (CḊO2) (19). CḊO2 may be improved in the face of an unchanged cerebral 
blood flow (CBF), where CBF is subject to the opposing influences of hypocapnia-induced 
cerebral vasoconstriction (via hyperventilation) and hypoxia-induced cerebral vasodilation (1).  
 
At least some of the adaptations that compensate for a reduced PIO2 in chronic hypoxia may be 
achievable with an IH protocol. The principal beneficial response to IH that mimics 
acclimatization is considered to be an increase in CaO2 via early respiratory changes related to an 
increase in hypoxic chemosensitivity (7,10,28). In contrast, the evidence is largely unsupportive 
of an increase in [Hb] or Hbmass with IH protocols (26), likely due to an insufficient total 
duration of hypoxic exposure (32). However, alterations are more rapid in severe hypoxia (37), 
and may be possible with an IH protocol involving exercise training (34). 
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Few studies have investigated exercise tolerance in severe hypoxia following IH protocols 
conducted at the same PIO2, and some have shown improvements in whole-body exercise 
tolerance in the severe-intensity domain (e.g. (5,7)). However, neither of these examples 
included a control group. To our knowledge, no study has investigated central and peripheral 
fatigue following an IH intervention. Therefore, the aims of this study were to determine whether 
(i) exercise tolerance in severe hypoxia could be improved following an IH protocol in 
comparison to a control protocol in normoxia and (ii) exercise-induced central fatigue would be 
alleviated following an IH protocol. It was hypothesised that (i) an IH protocol would result in an 
improvement in exercise tolerance in severe hypoxia and (ii) the central contribution to 
neuromuscular fatigue would be alleviated following an IH protocol. 
 
METHODS 
Participants 
Twenty-one participants were fully informed of the procedures and risks involved and provided 
written consent to participate. All participants were male, non-smokers, free from 
contraindications to experimental procedures including any history of cardiorespiratory or 
neurological disease, lowlanders, and had not visited altitudes ≥ 1000 m in the 3 months 
preceding the study. Participants were regularly physically active at a recreational level and were 
instructed to refrain from strenuous training for the duration of the experimental protocol. 
Participants were matched for normoxic peak O2 uptake (  O2peak) and randomly assigned 
(GraphPad Software Inc, USA) to one of two treatment groups: IH or control. Nineteen 
participants completed all trials (IH: n = 11,   O2peak 3.32 ± 0.42 L·min-1, age 23 ± 2 years, height 
180 ± 6 cm, body mass 76.4 ± 13.7 kg; and control: n = 8, 3.48 ± 0.36 L·min-1, 22 ± 4 years, 180 
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± 6 cm, 83.0 ± 5.5 kg). The study was approved by the university research ethics committee and 
was performed according to the Declaration of Helsinki. 
 
Experimental Design 
For each participant, all testing was performed at the same time of day ± 1 h. Over two 
familiarization visits, participants were accustomed to (i) the neuromuscular assessment and 
cycle ergometer, and (ii), the optimised carbon monoxide rebreathing (oCOr) method (Figure 
1A). On a third visit,   O2peak was obtained from a normoxic incremental cycling test (5 W·12 s-1 
from 80 W, preceded by a 3-min prior exercise at 50 W). Peak power ( peak) was derived as the 
highest power averaged over 30 s (IH: 309 ± 23; control: 313 ± 20 W). All subsequent cycling 
trials and both interventions were performed inside a large, purpose-built chamber (The Altitude 
Centre, UK; ambient temperature 19 ± 1°C, relative humidly 40 ± 2%, barometric pressure 760 ± 
2 mmHg). Normobaric, poikilocapnic hypoxia was delivered and maintained at a PIO2 of 82 ± 1 
mm Hg via nitrogen enrichment (equivalent to ~ 4700 m above sea level).  
 
All participants performed a constant-power cycling trial to task failure (TTF) before the 
intervention (≥ 48 h after the incremental exercise test) and after the intervention (48 h after the 
final exposure). The pre-intervention TTF is referred to as TTF-Pre. Following the intervention, 
there was no significant change in the performance of the control group (see Results section). As 
such, the post-intervention TTF was treated as an ‘isotime’ trial (ISO). In the IH group, there was 
a significant increase in TTF post-intervention (TTF-Post). The IH group performed an additional 
isotime trial (ISO = TTF-Pre) 48 h after TTF-post. Total Hb mass was measured before the 
intervention and 72 h after the final exposure. 
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The Intervention 
Over 14 ± 2 days, participants in the IH group performed 10 hypoxic exposures of 2-h duration. 
The control group completed an identical protocol in normoxia (PIO2 149 ± 1 mmHg). During 
exposure 1, 5 and 10, participants remained seated for 2 h. During the remaining sessions, 
participants undergoing IH were seated for 90 min and cycled for 30 min at 25%  peak. During 
the first exercise bout in the control group, the power was adjusted to produce the same heart rate 
(HR) as for the IH group (131 b·min-1). This power was fixed for the remaining exercise bouts 
(38 ± 2%  peak). Arterial O2 saturation was estimated using a pulse oximeter (SpO2) with a 
fingertip sensor placed on the participant’s right index finger (PalmSAT 2500 and 8000AA, 
Nonin Medical Inc, Minnesota, USA). HR (Polar Electro, Tampere, Finland) and SpO2 were 
recorded at 10-min intervals at rest, and 5-min intervals during exercise. Symptoms of AMS 
were assessed at 10-min intervals using the Lake Louise Questionnaire (LLQ) (33), with the 
sleep questions removed. 
 
During the intervention, participants were naïve to the aims of the study and blinded to the O2 
levels inside the chamber, their HR, SpO2 and power during cycling. To assess the blinding 
procedures after completion of the final visit, participants were asked to complete a brief 
questionnaire to indicate whether (i) their exposures were in ‘severe hypoxia (more than 4000 m 
above sea level)’ or ‘normoxia (sea level)’, and (ii) if they were ‘certain’, ‘fairly sure’ or 
‘uncertain’ about their answer. In response to (i), 53% of participants answered correctly and in 
response to (ii), 74% indicated that they were ‘uncertain’ about their answer. 
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Total Hemoglobin Mass 
The oCOr was used to derive Hbmass, blood volume and plasma volume (38). A detailed 
description of the equipment and specific methods used has previously been described (45). Test-
retest reliability was evaluated prior to the study with eight recreationally-active males (Hbmass: 
CV 3.9%, ICC 0.94, TEM 36 g; plasma volume: CV 3.3%, ICC 0.92, TEM 43 mL; blood 
volume: CV 3.1%, ICC 0.94, TEM 66 mL). 
 
Constant-Power Cycling Trials 
Upon arrival to the laboratory, participants provided a mid-stream urine specimen. Euhydration 
was accepted as a urine specific gravity of < 1.020 g.mL-1 and osmolality < 700 
mOsmols.kgH2O-1. Following 3 min at 50 W, power output was increased to 60%  peak (IH: 187 
± 14 W; control: 188 ± 12 W). Trials were performed on an electromagnetically-braked cycle 
ergometer (SRM High Performance Ergometer; Schroberer Rad Meβtechnik, Jülich, Germany) 
with body position and self-selected cadence determined during familiarization, and replicated 
for the duration of the study. Cadence (87 ± 4 rev·min-1) was the only real-time feedback 
participants received and verbal instructions were given should participants drift by ≥ 4 rev.min-1 
for ≥ 5 s. The nature and frequency of verbal encouragement was replicated across trials. Task 
failure was defined as a drop to ≤ 70% of self-selected cadence for > 5 s, despite strong verbal 
encouragement.  
 
Within-Exercise Measures 
Transcranial Doppler sonography was used to measure blood flow velocity in the left middle 
cerebral artery (MCAv). The same experimenter isonated the motor cortex segment of the MCA 
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over the left temporal window using a 2 MHz probe on each visit. Signal quality was optimised 
and the probe was fixed in position within an adjustable headpiece. Continuous traces of the 
maximal velocity envelope were recorded and processed offline for determination of beat-by-
beat mean velocity. Pulmonary ventilation and gas exchange were measured using a breath-by-
breath system (Metalyzer 3B, Cortex Biophysik, Leipzig, Germany). Following orientation to the 
scales, RPE and breathlessness were obtained using the Borg RPE scale and the modified Borg 
CR10 Scale, respectively. RPE, breathlessness, HR, SpO2 were recorded at 1-min intervals. 
Resting [Hb] in combination with SpO2 was used to estimate CaO2 at rest and throughout exercise 
in all conditions using the equation CaO2 = [Hb] × 1.39 × (SpO2 / 100). Subsequently, an index of 
CḊO2 was calculated as the product of MCAv and estimated CaO2. The estimation of CḊO2 in 
this study is based on the assumption that MCAv is a valid surrogate of MCA blood flow. There 
are uncertainties about the constancy of MCA diameter which prelude this assumption (see (1)), 
and as such, the data should be interpreted with due caution. 
 
Neuromuscular Assessment 
Neuromuscular data were captured using a data acquisition system and analysed offline using 
custom-made macroinstructions (PowerLab 26T and LabChart Vv7, ADInstruments Ltd, Oxford, 
UK). Prior to the neuromuscular assessment, optimal coil position and resting motor threshold 
were determined (Figure 1B, described below). The neuromuscular assessment (Figure 1C) was 
completed in 205 s pre- and post-exercise and was performed within the chamber. The first 
maximal voluntary contraction (MVC) was performed ≤ 40 s after task failure.  
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Knee-Extensor Force 
Participants sat upright on a custom-built chair with the knees and hips at 90 of flexion and 
were secured using straps across trunk and shoulders. Knee-extensor force was measured using a 
calibrated load cell (Tedea Huntleigh 615, Vishay, Basingstoke, UK) positioned directly behind 
the point of applied force and connected to a noncompliant cuff attached around the participant’s 
right leg, 1 - 2 cm superior to the ankle malleoli.  Following a set of preparatory contractions (2 x 
50%, 2 x 75% and a minimum of 2 x 100% ‘efforts’), MVCs were performed for 3 - 5 s with 
strong verbal encouragement and visual feedback of force. MVC force was measured as the 
highest 500-ms plateau.  
 
Electrical Stimulation of the Femoral Nerve 
Single electrical stimuli (200 µs pulse width) were delivered to the right femoral nerve via 5 cm2 
surface electrodes (CF5050B, Nidd Valley Medical, Hampshire, UK) and a constant-current 
stimulator (DS7AH, Digitimer Ltd, Hertfordshire, UK). The cathode was positioned over the 
femoral nerve, high in the femoral triangle. The anode was placed midway between the greater 
trochanter and the iliac crest. The site of stimulation that produced the highest mechanical twitch 
force and peak-to-peak M-wave amplitude in the vastus lateralis (VL) was located. Stimulations 
were delivered at increasing intensity (10 mA + 20 mA) until no further increase in either twitch 
force or M-wave amplitude could be elicited. The plateau intensity was increased by 30% to 
ensure supramaximality (254 ± 53 mA). Femoral nerve stimulation (FNS) was delivered during 
and within 2 s of MVCs to quantify M-waves, potentiated twitch force (Qtw,pot) and VAFNS. 
VAFNS was calculated using the interpolated twitch technique (ITT) where the amplitude of the 
A
C
C
E
P
TE
D
Copyright © 2017 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
 
superimposed twitch (SIT) was normalized to the corresponding Qtw,pot using the equation VAFNS 
(%) = (1-(SIT/Qtw.pot))×100 (7). 
 
Transcranial Magnetic Stimulation 
Single TMS pulses (1-ms duration) were delivered with a 110-mm diameter concave double-
cone coil powered by a mono-pulse magnetic stimulator (Magstim 2002, The Magstim Company 
Ltd, Whitland, UK) with a postero-anterior intracranial current flow. Optimal coil position 
(location eliciting the largest motor evoked potential (MEP) in the VL and a concurrent small 
MEP in the biceps femoris (BF) with stimulations delivered at 70% maximal stimulator output 
(MSO)) was measured relative to the vertex and clearly marked on the scalp with indelible ink. 
Resting motor threshold (rMT) was determined at the beginning of each TTF visits using the 
modified relative frequency method (20), defined as the intensity that elicited a VL MEP of ≥ 
0.05 mV in three out of six trials (42). Stimulations were delivered at 130% rMT (18) which 
corresponded to 70 ± 11% MSO (VL MEP/Msup area of 60 – 70% at 50 - 75% MVC). The BF 
MEP response was < 20% of the VL response at all contraction strengths. Participants performed 
three sets of contractions (100%, 75% and 50% MVC, separated by 10 s rest) with 20-s rest 
between sets (Figure 1C). The estimated resting twitch (ERT) was estimated by taking the y-
intercept of a linear regression (baseline: r = 0.95 ± 0.04; fatigued state: r = 0.95 ± 0.05) of the 
SIT-voluntary force relationship (43). VATMS was subsequently quantified using the equation 
VATMS (%) = (1-(SIT/ERT))*100. Where regressions were not adequately linear (defined as r < 
0.85 (16)), or an individual set or contraction was problematic, it was excluded and the mean of 
the two sets was used to estimate ERT. This occurred in < 5% of evaluations. 
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Electromyographic Responses 
Surface electromyography (EMG) was recorded from the right VL and the lateral head of the BF. 
The skin was shaved, abraded and cleaned with an alcohol wipe. Two single-use Ag/AgCI 
electrodes (33 x 22 mm, Kendall H59P, Mansfield, MA, USA) were placed in a bipolar 
configuration (inter-electrode distance of 20 mm) over the muscle belly. The reference electrode 
was placed over the patella. Electrode placement was marked with indelible ink to ensure 
consistent positioning between visits. Raw EMG signal was amplified (x 1000), digital band-pass 
filtered (20 Hz – 2 kHz) and sampled at 4 kHz. The peak-to-peak amplitude and area under the 
curve of the VL Mmax and Msup, and VL and BF MEP at each contraction strength were 
quantified. VL MEPs were normalised to the corresponding maximal M-wave at rest (Mmax) or 
during an MVC (Msup). The cortical silent period (CSP) was measured during three MVCs from 
stimulus artefact to the continuous resumption of EMG, determined by the same experimenter 
using visual inspection of the EMG trace. 
 
Statistical Analyses 
Data are presented as mean ± SD throughout. All statistical procedures were completed using 
IBM SPSS v22. Prior to ANOVA, homogeneity of variance was confirmed using Levene’s test. 
Data were checked for sphericity using Mauchly’s test and if violated, the Greenhouse-Geisser 
correction was applied. Two-way mixed ANOVA were performed to determine differences in 
HR, SpO2 and RPE during the intervention protocol (exposure × group) and differences in 
exercise time and HBmass before and after the intervention (trial × group). For neuromuscular 
and within-exercise data, three-way mixed design ANOVA were performed (trial × time × 
group), where trial denotes TTF-Pre vs. ISO. For within exercise data, a resting baseline, minute 1 
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– 4 and the final minute of constant-power cycling were included in the statistical analysis given 
the duration of the shortest exercise time. Following a significant overall interaction, two-way 
repeated measures ANOVA were performed in each group (trial × time). To account for the 
difference in exercise time after the IH intervention, two-way repeated measures ANOVA were 
performed in the IH group alone (trial × time), where trial denotes TTF-Pre vs. TTF-Post. Following 
a significant interaction effect, post-hoc analysis was conducted using Tukey’s HSD tests to 
localize differences. Statistical significance was set at p < 0.05. Effect sizes are presented as 
partial eta squared (ηp2) for main and interaction effects and Cohen’s dav for pairwise 
comparisons. 
 
RESULTS 
Exercise Time (Figure 2) 
Following an interaction of trial × group, exercise time did not differ significantly before and 
after the control intervention (535 ± 124 vs. 557 ± 131 s, p > 0.05; d = 0.18), but improved by 35 
± 18% after the IH protocol (535 ± 213 to 713 ± 271 s, p < 0.05; d = 0.73).  
 
Haematological Measures 
Due to a technical issue, nine participants in the IH group and four participants in the control 
group completed the post-intervention oCOr measurement 72 h after the final exposure. No 
differences were found for any Hbmass, plasma volume, blood volume or [Hb] before and after 
the intervention (all p < 0.05) (see Table, Supplemental Digital Content 1, Haematological 
measures before and 72-h after an intervention of intermittent hypoxia (IH) or control protocol in 
normoxia, http://links.lww.com/MSS/A993). 
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Maximal Voluntary Force 
Following an interaction of trial × time × group, MVC was reduced from pre- to post-exercise in 
the control group (time: p < 0.001; ηp2 = 0.92), with no differences before and after the 
intervention (trial × time: p = 0.69; ηp2 = 0.02). The exercise-induced decrease in MVC in the IH 
group was alleviated at isotime after the intervention (trial × time: p < 0.001; ηp2 = 0.78, post-
exercise MVC: p < 0.05; d = 0.67). When cycling continued to task failure in TTF-Post, the 
resulting decrease in MVC (Figure 3) did not differ before and after the intervention (trial × time: 
p = 0.16; ηp2 = 0.19).  
 
Central Fatigue and Corticospinal Excitability 
Following an interaction of trial × time × group, VATMS was reduced post-exercise in the control 
group (time: p < 0.001; ηp2 = 0.92), with no differences before and after the intervention (trial × 
time: p = 0.52; ηp2 = 0.06). As presented in Figure 3, the exercise-induced decrease in VATMS 
(i.e. central fatigue), was alleviated at isotime after the IH intervention (trial × time: p = 0.012; 
ηp
2 = 0.49, post-exercise VATMS: p < 0.05; d = 1.20). When cycling continued to task failure, the 
decrease in VATMS did not differ before and after the intervention (trial × time: p = 0.296; ηp2 = 
0.11). The overall pattern in regards to VAFNS was analogous to that described for VATMS (Table 
1). No differences were found for corticospinal excitability parameters (all p > 0.05) and data for 
100% MVC are presented in Table 1. 
 
Peripheral Fatigue and Neuromuscular Transmission 
Following an interaction of trial × time × group, Qtw,pot was reduced post-exercise in the control 
group (time: p < 0.001; ηp2 = 0.93), and the level of peripheral fatigue did not differ after the 
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normoxic protocol (trial × time: p = 0.053; ηp2 = 0.44). In contrast, the exercise-induced decrease 
in Qtw,pot was alleviated at isotime after the IH intervention (trial × time: p = 0.004; ηp2 = 0.57, 
post-exercise Qtw,pot: p < 0.05; d = 0.94). However, the level of peripheral fatigue reached at task 
failure did not differ before and after the IH intervention (trial × time: p = 0.079; ηp2 = 0.28). No 
differences were found for parameters relating to neuromuscular transmission (all p > 0.05) and 
data are presented in Table 1. 
 
Within-Exercise Measures 
Data for HR, RPE, breathlessness and pulmonary gas exchange are presented in Table 2. 
 
Pulmonary Ventilation 
Following an interaction of trial × time × group,   E was found to be higher at isotime following 
the IH intervention (p < 0.05; d = 0.27). A higher   E was also observed in TTF-Pre vs. TTF-Post (p 
= 0.004; ηp2 = 0.42), such that   E was 17 ± 21% higher at task failure after the intervention (p < 
0.05; d = 0.43). 
 
Hemoglobin Oxygen Saturation  
Following an interaction of trial × time × group, the profile of decreasing SpO2 during exercise in 
severe hypoxia (Figure 4) did not differ before and after the intervention in the control group 
(trial × time: p = 0.45; ηp2 = 0.12). This is in contrast to the IH group (trial × time: p = 0.001; np2 
= 0.35), where SpO2 was higher at isotime after the intervention (p < 0.05; d = 1.57). However, 
when exercise time was prolonged to task failure, end-exercise SpO2 reached the same level as in 
TTF-Pre (p > 0.05; d < 0.1). 
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Arterial Oxygen Content 
Following an interaction of trial × time × group, in the control group, the profile of CaO2 did not 
differ before and after the intervention (trial × time: p = 0.741; ηp2 = 0.08). This is in contrast to 
the IH group (trial × time: p < 0.001; ηp2 = 0.36), where CaO2 was higher at isotime: 16.8 ± 1.1 
vs. 15.9 ± 0. 8 mL O2 ·dL-1; p < 0.05; d = 0.90). However, at task failure, although the interaction 
of trial × time was significant (p = 0.041; ηp2 = 0.20) no differences were found when post-hoc 
analysis was conducted.  
 
Cerebral Blood Flow Velocity and Cerebral Oxygen delivery  
Due to an inadequate signal, one participant was removed from the analysis of MCAv and the 
derived estimate of CḊO2 (IH n = 11, control n = 7). No significant differences were found in the 
profile of MCAv or CḊO2 (i.e. interaction effects) before and after the interventions (all p > 
0.05). Data are presented in Figure 4. 
 
The Intervention Protocols 
No incidence of AMS (LLQ score ≥ 3) was observed. Following an interaction of exposure × 
group, in the IH group, resting SpO2 improved during exposure 9 and 10 (e.g. 79 ± 6% vs.  83 ± 
4% for exposure 1 vs. 10, p < 0.05; d = 0.59). Exercising SpO2 in IH improved from the first to 
the last exercise bout (74 ± 4 vs, 78 ± 4, p < 0.05; d = 1.0). SpO2 was 98 ± 1% at rest and 97 ± 
1% during exercise in the control group and did not differ over exposures 1 to 10 (all p > 0.05). 
No differences were found between groups in exercising HR or RPE (all p > 0.05). During the 
first session of exercise, HR was 131 ± 15 b·min-1 and 131 ± 6 b.min-1 in IH and control, 
respectively. By exposure 10, exercising HR reduced to 122 ± 14 b·min-1 and 124 ± 5 b·min-1 in 
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IH and control, respectively. In both groups, RPE was 12 ± 1 on exposure 1, and 11 ± 1 by 
exposure 10. 
 
DISCUSSION 
The aim of the present study was to assess both whole-body exercise tolerance and the 
mechanisms of neuromuscular fatigue in severe hypoxia following an IH protocol. Exercise 
tolerance in severe hypoxia improved following an IH protocol completed in the same severity of 
hypoxia, but not in a control group who completed a matched protocol in normoxia. This is the 
first study to show that the development of neuromuscular fatigue with whole-body exercise in 
severe hypoxia is attenuated following an IH protocol. In particular, central fatigue was lower at 
the same exercise time achieved prior to the IH intervention. 
 
The IH Protocol and Exercise Tolerance in Severe Hypoxia 
The IH protocol involved ten exposures to a low PIO2 (82 mmHg) at rest (2-hour duration) with 
30 minutes of moderate-intensity exercise (25%  peak) within seven of the sessions. Selecting an 
optimal hypoxic dose that is both suitable for practical application and capable of eliciting 
beneficial adaptations is challenging because protocols vary considerably in the literature 
depending on the aim of the specific study. Nevertheless, in the design of the present study, we 
considered the characteristics of IH protocols (in relation to the combination of exposure and 
training, the training intensity and duration and the total hypoxic dose) and exercise performance 
in severe hypoxia as reviewed by Muza et al in 2007 (28) and investigated in later studies (e.g. 
(6,7,9,10,24)). In the initial IH sessions of the present study, there was an anticipated and 
pronounced arterial hypoxemia at rest (SpO2 < 80%), which improved in the last two sessions (~ 
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83%). During the first exercise bout in IH, SpO2 decreased further, to < 75%. This improved 
significantly by the final exercise bout alone (~ 78%). Comparable improvements in SpO2 during 
hypoxic exercise have been reported during constant-power exercise following an IH protocol 
(e.g. (7)), although not consistently (6). 
 
Constant-power cycling in AH resulted in task failure in 8.9 ± 2.9 min. During the intervention, 
power output was not equivalent in IH and control due to the increase in relative exercise 
intensity at the same absolute power output in severe hypoxia. To detect changes due to the 
intervention, the exercise intensity in normoxia was adjusted to match heart rate recorded during 
the first exercise bout in the IH group (~ 131 b·min-1). In matching the cardiovascular demand of 
the exercise, it is noted that exercise was also performed at the same perceived exertion (RPE 
12), where SpO2 was significantly greater for the control group (98%). It was therefore hypoxic 
exposure and/or hypoxic exercise that elicited an improvement in exercise tolerance in severe 
hypoxia in the IH group. Although adaptations cannot be attributed to one of these stressors 
alone, seven sessions of matched-intensity exercise in normoxia did not improve exercise 
tolerance in severe hypoxia. Indeed, there was no statistical difference from baseline exercise 
time in the control group, where the mean difference (36 s) was deemed too small to warrant, 
and justify from an ethical standpoint, a further trial in severe hypoxia. The improvement in 
exercise time in the IH group was substantial (~ 35%) and systematic (range: 1.1 – 5.2 min). 
Given the successful blinding to the intervention and the blinding of all real-time feedback 
during the cycling trials, we consider it to be highly unlikely that the improvement in exercise 
tolerance was due to an anticipated benefit of IH (i.e. a placebo effect). 
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Neuromuscular Fatigue in Severe Hypoxia 
Constant-power cycling induced neuromuscular fatigue in AH, indicated by a ~ 20% decrease in 
the ability to produce maximal voluntary force in the knee extensors. After the IH protocol, the 
reduction in MVC force was less pronounced at isotime (~ 12%), but reached pre-intervention 
levels when exercise continued to task failure. One of the primary limitations to whole-body 
exercise tolerance in severe hypoxia is exacerbated central fatigue (4,17). The decrease in VATMS 
from pre- to post-exercise in severe hypoxia prior to the intervention was similar to that reported 
previously in AH (17,19). Goodall et al (19) found a 12% decrease in VATMS following constant-
power cycling in AH. After acclimatization, central fatigue was alleviated at isotime and this was 
attributed, in part, to an improved cerebral O2 availability. However, due to the constraints of the 
wider project protocol, an improvement in exercise tolerance was not confirmed. In the present 
study, the IH protocol resulted in an alleviated central fatigue at isotime, where the decrease 
from baseline was no longer significant. When exercise was permitted to continue to task failure 
after the IH intervention, central fatigue (and indeed the overall decrease in MVC force) 
ultimately reached the same levels that coincided with task failure before the intervention (12% 
decrease in VATMS). We therefore propose that the alleviation of the central contribution to 
neuromuscular fatigue is an important, though not necessarily the singular, mechanism by which 
exercise was prolonged following the IH protocol. 
 
The mechanisms for the alleviation of central fatigue may be related to improved cerebral 
oxygenation secondary to an improved CḊO2 (11). A number of researchers have substantiated a 
link between a reduced CḊO2 and the impairment to whole-body exercise that occurs in severe 
hypoxia (e.g. (48)). However, a challenge in the research area is isolating the influence of a 
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systemic improvement in oxygenation (i.e. SpO2) from an improvement in cerebral oxygenation. 
Isolating the effect of systemic and cerebral oxygenation requires innovative experimental 
procedures such as CO2 clamping, which increases CBF and therefore CḊO2. Interestingly, 
increasing CḊO2 in AH has not been shown to improve exercise tolerance (12). However, the 
method is problematic during whole-body exercise (e.g. due to increased respiratory muscle 
work), and has only been performed with a neuromuscular assessment in a single-limb model 
(36). In the present study, although the estimate of CaO2 was higher at isotime after the IH 
intervention (due to the improvement in SpO2 and not [Hb]), CBF and CḊO2 were not, despite 
the improvement in exercise time. The relationship between CḊO2, exercise tolerance and central 
fatigue in severe hypoxia remains unresolved (39). However, the eventual use of O2 in 
mitochondrial oxidation depends not only on CḊO2 but on the capillary O2 tension, the O2 
conductance from capillary to mitochondria and the cerebral metabolic rate of O2 (31). Under 
normoxic conditions there is a tight coupling of the cerebral metabolic rate of O2 and CBF (30). 
During physiological increases in neuronal activity (e.g., synaptic transmission and firing rate), 
there is an uncoupling of these variables such that CBF largely exceeds the consumption of O2 in 
tissue (13). It may be that the signal for reduced central motor output depends on a step that is 
uncoupled with CḊO2 during whole-body exercise in severe hypoxia, and this may be altered 
with an IH protocol. However, this is speculative and further studies on the relationship between 
cerebral O2 metabolism and central fatigue in severe hypoxia are warranted. 
 
Neither the CSP, as a representation GABA(B) receptor-mediated inhibition of cortical 
excitability (40), or the MEP, used to assess changes in the state of excitability in the 
corticospinal system (8), were modulated pre- to post-exercise exercise in severe hypoxia, or by 
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the intervention itself. Previous findings indicate time-dependent increases in corticospinal 
excitability (at rest) with severe hypoxia (3,35). However, both studies used continuous 
exposures (3 h and 14 days, respectively) and it may be that the discontinuous nature of an IH 
protocol (i.e. the wash-out in normoxia) masked any transient neurophysiological alterations 
over the time-course of an IH protocol. This warrants further investigation, given the therapeutic 
potential of IH (29,46). 
 
As evidenced by an increase in   E and decrease in PETCO2 following the IH intervention, the IH 
protocol used conferred a level of ventilatory adaptation to hypoxic exercise. This resulted in an 
increase in SpO2 during constant-power cycling following the IH protocol. A proposed threshold 
of arterial hypoxemia where hypoxia-sensitive mechanisms originating in the CNS are thought to 
override other inhibitory influences on central motor output (i.e. afferent feedback from the 
exercising limb) during whole-body exercise, is below 70-75%  (4,11). We note that at isotime 
following the IH intervention, SpO2 was 79% (vs. 70% at task failure in TTF-Pre). A number of 
previous studies have shown similar ventilatory adaptations with IH which resulted in an 
increased   E and SpO2 during hypoxic exercise, augmented by increased hypoxic chemo-
sensitivity (7,10,28). Limited studies have investigated exercise tolerance in severe hypoxia, but 
some have shown improvements in cycle time-trial performance comparable to CH (5,7).  More 
recently, a study that used four exposures of 4 h to PIO2 ≈ 92 mmHg, increased exercise   E and 
SpO2 were observed without changes in cerebral oxygenation or constant-power cycling to task 
failure in hypoxia (10). A beneficial effect of IH on exercise tolerance in severe hypoxia is not a 
consistent finding (6,9), and the disparity may be due to differences relating to protocol and 
hypoxic dose.  
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In the present study, we found no change in Hbmass, plasma volume or [Hb]. Hbmass is a 
measure of O2 carrying capacity that is not subject to vascular volume shifts. A recent study 
reported an increase in Hbmass following an IH protocol in moderate hypoxia (34). This is 
surprising given the evidence suggesting that the total duration of hypoxic exposure required to 
produce a change in Hbmass is equivalent to more than ~ 7 d continuous exposure (32).  
 
The Peripheral Contribution to Neuromuscular Fatigue 
In AH, peripheral locomotor muscle fatigue was identified as a decrease in potentiated 
quadriceps twitch force by ~ 20%. The results of earlier studies indicate that in the severe-
intensity domain, the level of peripheral fatigue at task failure in AH is less than that reached at 
task failure in normoxia (> 30%) (e.g. (4)). In severe hypoxia, task disengagement occurs before 
metabolic disturbance reaches levels attained at the end of the same task performed in normoxia. 
For this reason, we do not consider peripheral fatigue to be a major limitation to whole-body 
exercise under these specific and extreme conditions. Nevertheless, following the IH protocol, 
the decrease in Qtw.pot was less prominent at isotime (~ 16%). This is in contrast to the findings 
following a 14-day exposure to high altitude, where the development of peripheral fatigue was 
not alleviated (3). The mechanisms for this are equivocal but may be related to a lower limb 
blood flow and therefore limb O2 delivery, an important regulator of peripheral fatigue (2). 
Speculatively, in the present study, an unchanged limb blood flow coupled with an increase in 
CaO2 is one explanation for the reduction in peripheral fatigue. Alternatively, an exercise x 
hypoxia interaction may have induced skeletal muscle adaptations (21) that delayed the 
development of peripheral fatigue such that it was lower at isotime, but ultimately reached the 
same levels at task failure. 
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The decision to disengage from a task can be described as an internally coordinated response to 
internal and/or external stimuli, i.e. a behaviour (23). It would be simplistic to ascribe this solely 
to lower-level neurophysiological properties (22). The perception of the sensations associated 
with hypoxic exercise is an important consideration, and both perceived limb discomfort and 
breathlessness (notably, in spite of a higher   E), were also lower at isotime. We further 
acknowledge that task failure in severe hypoxia is likely to have a cognitive component (44). 
Disentangling the relative contributions of these complex and interactive processes is a major 
challenge for exercise scientists and in hypoxic physiology, warrants further consideration. 
 
In summary, the novel findings of this study were that whole-body exercise tolerance in severe 
hypoxia was prolonged following a protocol of intermittent hypoxia involving exposure and 
exercise, but not in a control group who performed a matched protocol in normoxia. At isotime 
following the IH intervention, the central contribution to neuromuscular fatigue was alleviated. 
These alterations occurred alongside an augmented ventilatory response to hypoxic exercise 
which improved the pronounced arterial hypoxemia induced by hypoxic exercise in the severe-
intensity domain. 
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FIGURE CAPTIONS 
 
Figure 1. Overview of the experimental protocol (A), the constant-power cycling trial visits (B) 
and the neuromuscular assessment (C). Fam1 and Fam2, familiarisation sessions one and two; 
Max, measurement of maximal O2 uptake and peak power; oCOr, optimised carbon monoxide 
rebreathing method; TTF, trial to task failure; ISO, constant-power cycling to isotime; rMT, 
resting motor threshold; FNS, femoral nerve stimulation; TMS, transcranial magnetic 
stimulation. *Denotes exposures on which 30 min exercise was performed. †Indicates that this 
trial did not differ from TTF-Pre and was treated as an isotime trial. 
 
Figure 2. Time to task failure (s) with constant-power cycling in severe hypoxia before (Pre) and 
after (Post) a protocol of intermittent hypoxia (IH) or a matched protocol in normoxia (Control). 
*p < 0.05, Pre vs. Post. The mean is plotted as the closed circle.  
 
Figure 3. Neuromuscular measures made Pre- (open bars) and Post- (closed bars) constant-
power cycling in severe hypoxia, before and after a protocol of intermittent hypoxia (IH, left 
column) or a matched protocol in normoxia (Control, right column). MVC, maximal voluntary 
contraction; VATMS, cortical voluntary activation; Qtw,pot, potentiated quadriceps twitch force; 
TTF, time to task failure. *p < 0.05 vs. Post. †p < 0.05, Post-exercise in TTF-Pre. 
  A
C
C
E
P
TE
D
Copyright © 2017 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
 
Figure 4. Hemoglobin oxygen saturation (SpO2, top row), cerebral blood flow velocity (MCAv, 
middle row) and cerebral oxygen delivery index (CḊO2, bottom row) in the intermittent hypoxia 
group (IH, left column) and control group (right column) during TTF-Pre (open circles) and 
isotime (grey circles). *p < 0.05 vs. ISO. 
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Figure 4 
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Table 1. Neuromuscular parameters pre and post constant-power cycling to task failure, before and after a protocol of intermittent 
hypoxia (IH) or a matched control protocol in normoxia. 
 
 TTF-Pre ISO TTF-Post 
 Pre Post Pre Post Pre Post 
Mmax amplitude (mV) 
IH 6.2 ± 1.9 5.6 ± 1.6 6.5 ± 3.2 6.1 ± 3.5 5.7 ± 2.2 5.8 ± 1.9 
CON 6.0 ± 2.6 4.9 ± 2.4 5.9 ± 2.4 5.3 ± 2.0   
Mmax area (mV.ms
-1
) 
IH 40.5 ± 11.6 40.8 ± 11.9 44.2 ± 10.1 39.3 ± 17.4 37.4 ± 16.0 42.1 ± 16.2 
CON 40.4 ± 16.4 34.4 ± 19.1 40.5 ± 15.3 40.1 ± 16.9   
VAFNS (%) 
IH 92 ± 3 85 ± 4* 93 ± 5 90 ± 4† 93 ± 3 86 ± 3* 
CON 93 ± 3 86 ± 3* 92 ± 3 85 ± 5*   
Msup amplitude (mV) 
IH 6.2 ± 2.1 5.8 ± 1.6 7.3 ± 3.3 6.6 ± 3.6 6.3 ± 2.1 5.8 ± 1.9 
CON 7.4 ± 2.1 6.0 ± 3.0 7.1 ± 2.7 5.5 ± 2.4   
Msup area (mV.ms
-1
) 
IH 41.1 ± 11.5 36.7 ± 8.1 45.4 ± 16.0 41.5 ± 18.1 43.0 ± 12.4 36.5 ± 12.9 
CON 38.3 ± 11.0 39.7 ± 21.4 37.4 ± 11.5 32.6 ± 15.7   
MEP/Msup amplitude 
IH 0.53 ± 0.12 0.50 ± 0.13 0.46 ± 0.13 0.48 ± 0.15 0.50 ± 0.18 0.54 ± 0.14 
CON 0.40 ± 0.10 0.46 ± 0.12 0.50 ± 0.14 0.52 ± 0.07   
MEP/Msup area  
IH 0.63 ± 0.15 0.66 ± 0.15 0.56 ± 0.10 0.61 ± 0.17 0.59 ±0.13 0.71 ± 0.11 
CON 0.59 ± 0.10 0.58 ± 0.12 0.67 ± 0.13 0.73 ± 0.16   
CSP (ms) 
IH 169 ± 46 156 ± 45 179 ± 43 169 ± 50 183 ± 47 172 ± 48 
CON 179 ± 85 176 ± 77 174 ± 74 164 ± 70   
ERT/MVC (%) 
IH 21 ± 10 14 ± 5 20 ± 8 13 ± 4 20 ± 8 14 ± 6 
CON 25 ± 8 15 ± 7 21 ± 10 13 ± 8   
 
MVC, maximal voluntary contraction; Mmax, maximal muscle compound action potential; Msup, superimposed maximal muscle compound action 
potential; MEP, motor evoked potential, CSP, cortical silent period; ERT, estimated resting twitch. *p < 0.05 vs. pre-exercise. †p < 0.05 vs. post-
exercise in TTF-Pre. A
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Table 2. Within-exercise data at rest (following a 15 min wash-in period to severe hypoxia) and 
in the final minute of exercise during TTFs before and after an intermittent hypoxia protocol or a 
matched control protocol in normoxia. 
  TTF-Pre ISO A TTF-Post B 
  E  
(L·min
-1
) 
IH 
Rest 16.7 ± 5.8 17.7 ± 6.0 †# 18.3 ± 6.5 †# 
End-Ex 145. 1 ± 17.9 150. 1 ± 18.5 * 158.8 ± 21.9 * 
CON 
Rest 17.1 ± 4.8 18.9 ± 5.0    
End-Ex 151.2 ± 16.3 150.9 ± 16.8    
PETCO2 
 (mmHg) 
IH 
Rest 38.1 ± 4.8 33.8 ± 2.2 †#* 34.4 ± 3.2 †# 
End-Ex 28.1 ± 4.2 27.1 ± 3.9  24.7 ± 2.6  
CON 
Rest 33.7 ± 2.8 33.9 ± 3.4    
End-Ex 25.1 ± 2.4 25.1 ± 2.0    
  O2  
(L·min
-1
) 
IH 
Rest 0.52 ± 0.14 0.49 ± 0.15 † 0.50 ± 0.15 † 
End-Ex 2.42 ± 0.48 2.29 ± 0.32  2.41 ± 0.28  
CON 
Rest 0.52 ± 0.17 0.57 ± 0.12    
End-Ex 2.49 ± 0.29 2.47 ± 0.46    
  CO2 
 (L·min
-1
) 
IH 
Rest 0.62 ± 0.16 0.60 ± 0.18 † 0.61 ± 0.20 † 
End-Ex 3.60 ± 0.37 3.38 ±  0.33  3.34 ± 0.35  
CON 
Rest 0.61 ± 0.09 0.66 ± 0.16    
End-Ex 3.47 ± 0.31 3.47 ± 0.37    
  E/  CO2 (L·.min-
1) 
IH 
Rest 26.48 ± 4.00 29.57 ± 263 † 29.69 ± 2.20 †#* 
End-Ex 40.54 ± 4.57 42.02 ± 6.33  47.44 ± 3.34 * 
CON 
Rest 27.57 ± 4.64 28.89 ± 3.02    
End-Ex 43.60 ± 2.70 43.57 ± 4.34    
HR  
(b∙min
-1
) 
IH 
Rest 84 ± 6 80 ± 3 † 82 ± 5 † 
End-Ex 177 ± 6 172 ± 8  175 ± 7  
CON 
Rest 84 ± 9 85 ± 7    
End-Ex 173 ± 8 175 ± 7    
RPE 
IH End-Ex 20 ± 0 17 ± 2 †#* 20 ± 0 † 
CON End-Ex 20 ± 0 20 ± 0    
Dyspnoea 
IH End-Ex 10 ± 0 6 ± 2 †#* 10 ± 0 † 
CON End-Ex 10 ± 0 10 ± 0    
 
  E, minute ventilation; PETCO2, partial pressure of end-tidal carbon dioxide;   O2, oxygen uptake,   CO2, carbon 
dioxide production;   E /  CO2, ventilatory equivalent for carbon dioxide; HR, heart rate; RPE, rating of perceived 
exertion. A, TTF-Pre vs. ISO; B, TTF-Pre vs. TTF-Post in IH. #p < 0.05 main effect of trial; †p < 0.05 main effect of 
time, *p < 0.05 vs. TTF1. 
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Supplemental Digital Content 
 
 Haematological measures before and 72-h after an intervention of intermittent hypoxia (IH) or 
control protocol in normoxia.  
 
  Pre-Intervention Post-Intervention f(1,7) p np2 
Total Haemoglobin Mass (g) 
IH 875 ± 155 880 ± 112 
0.03 0.857 0.03 
Control 860 ± 117 860 ± 104 
Plasma Volume (mL) 
IH 937 ± 259 899 ± 188 
0.14 0.580 0.13 
Control 922 ± 127 914 ± 97 
Blood Volume (mL) 
IH 1812 ± 400 1778 ± 1281 
0.18 0.683 0.01 
Control 1781 ± 244 1774 ± 165 
Haemoglobin Concentration 
(g·dL-1) 
IH 16.5 ± 1.0 16.5 ± 1.0 
0.51 0.490 0.04 
Control 15.0 ± 0.1 15.4 ± 0.5 
 
IH, intermittent hypoxia. IH, n=9; control, n=4. ANOVA result is provided for the interaction of 
trial (pre- and post-intervention) x group (IH vs. control). 
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